QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 oppenheimer-maintains-outperform-on-ventyx-biosciences-raises-price-target-to-14

Oppenheimer analyst Jeff Jones maintains Ventyx Biosciences (NASDAQ:VTYX) with a Outperform and raises the price target from...

 ventyx-stock-is-rallying-thursday-whats-driving-the-surge

Ventyx Biosciences Inc (NASDAQ:VTYX) shares are surging Thursday after the company announced positive Phase 2 study results for...

 why-ventyx-vtyx-shares-soared-865-after-hours

Ventyx shares jumped 86.5% in after-hours trading after positive Phase 2 trial results.

 ventyx-biosciences-announces-positive-results-from-phase-2-trial-of-vtx3232-for-obesity-cardiovascular-risk-factors-vtx3232-monotherapy-achieved-80-reduction-in-hscrp-vtx3232-monotherapy-reduced-il-6-levels

Ventyx Biosciences, Inc. (Nasdaq: VTYX) ("Ventyx", "Company"), today announced positive results from its Phase ...

 clear-street-initiates-coverage-on-ventyx-biosciences-with-buy-rating-announces-price-target-of-11

Clear Street analyst Kaveri Pohlman initiates coverage on Ventyx Biosciences (NASDAQ:VTYX) with a Buy rating and announces P...

 ventyx-biosciences-q2-eps-038-beats-045-estimate

Ventyx Biosciences (NASDAQ:VTYX) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION